CANCER OF THE LIVER
Clinical trials for CANCER OF THE LIVER explained in plain language.
Never miss a new study
Get alerted when new CANCER OF THE LIVER trials appear
Sign up with your email to follow new studies for CANCER OF THE LIVER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental liver cancer drug shows promise in early trial
Disease control TerminatedThis phase 2 trial tested a drug called Taxoprexin (DHA-paclitaxel) in 13 people with advanced liver cancer that had not responded to prior treatments. The goal was to see if the drug could shrink tumors and how safe it was. The study was terminated early, so results are limited.
Matched conditions: CANCER OF THE LIVER
Phase: PHASE2 • Sponsor: American Regent, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New registry aims to sharpen liver tumor ablation techniques
Knowledge-focused TerminatedThis study tracked over 1,200 people with liver cancer who received microwave ablation, a procedure that uses heat to destroy tumors. Researchers collected data over 5 years to see how well the ablation worked and how long patients lived. The goal was to create better guidelines …
Matched conditions: CANCER OF THE LIVER
Sponsor: Ethicon, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC